SHOW

Dr. Manfredi Rizzo was born in Italy. He studied medicine and got the training in Internal Medicine in Italy. He spent several years in the United States, working as a Scientist at the Lawrence Berkeley National Laboratory, University of California, as well as at the Lipid Clinic of the University of California, Berkeley, under the direct supervision of Prof. Ronald M. Krauss, MD. There he was able to perform a number of studies on the patho-­­physiology, metabolism, atherogenicity and clinical properties of plasma lipids and lipoproteins, in patients with different metabolic disorders, including dyslipidemia, diabetes, obesity and the metabolicsyndrome.Dr. Rizzo is Associate Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy with a joint position in the Clinic of Internal Medicine at the University Hospital, where he is Head of the Unit of Diabetesand CardiovascularPrevention. Due to his long-­­standing research on metabolic disorders, he has been Invited as Visiting Professor at the Clinic of Endocrinology, Diabetes and Clinical Nutrition, University of Zurich, Switzerland. Also, Dr. Rizzo is currently the Director of the Department of Population Heath attheEuro-­­Mediterranean Institute of Science and Technology, Italy, as well as Adjunct Professor at the School of Medicine, Department of Internal Medicine, University of South Carolina,USA.Dr. Rizzo sits on the editorial board of 17 international journals. He has been the recipient of national and international fellowships and awards, and acted as reviewer for 100+ scientific international journals. The research work of Dr. Rizzo combines translational research (focus on the effects and mechanisms of action of lipid-­­loweringand anti-­­diabeticagents)and basicresearch (focus on novel cardiovascular risk factors), with 300+ scientific publications (total Impact Factor: >600. H-­­Index:29).